SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-003163
Filing Date
2023-03-08
Accepted
2023-03-08 16:59:47
Documents
80
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cycc-20221231x10k.htm   iXBRL 10-K 1979372
2 EX-4.10 cycc-20221231xex4d10.htm EX-4.10 172910
3 EX-10.16 cycc-20221231xex10d16.htm EX-10.16 50621
4 EX-23.1 cycc-20221231xex23d1.htm EX-23.1 2663
5 EX-31.1 cycc-20221231xex31d1.htm EX-31.1 12608
6 EX-31.2 cycc-20221231xex31d2.htm EX-31.2 12392
7 EX-32.1 cycc-20221231xex32d1.htm EX-32.1 6402
8 EX-32.2 cycc-20221231xex32d2.htm EX-32.2 6494
  Complete submission text file 0001558370-23-003163.txt   8157995

Data Files

Seq Description Document Type Size
9 EX-101.SCH cycc-20221231.xsd EX-101.SCH 54920
10 EX-101.CAL cycc-20221231_cal.xml EX-101.CAL 57715
11 EX-101.DEF cycc-20221231_def.xml EX-101.DEF 244032
12 EX-101.LAB cycc-20221231_lab.xml EX-101.LAB 453876
13 EX-101.PRE cycc-20221231_pre.xml EX-101.PRE 398695
74 EXTRACTED XBRL INSTANCE DOCUMENT cycc-20221231x10k_htm.xml XML 1174720
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50626 | Film No.: 23716845
SIC: 2834 Pharmaceutical Preparations